The Open Immunology Journal

ISSN: 1874-2262 ― Volume 10, 2020

Publish your Article in Open Access Model free of charge

Note: Average publication time of 18 days between final acceptance of revised manuscript and its publication


A. Mouzaki (Biography
A. Mouzaki

Athanasia Mouzaki, PhD, is a Professor of Laboratory Hematology and Transfusion Medicine, Immunohematology Research Laboratory, Division of Hematology, Dpt. of Internal Medicine, Medical School, University of Patras, Greece. Her training and research interests are in basic and clinical immunology with emphasis on T-cells and cytokines and their functions and malfunctions in immunopathology including autoimmunity, transplantation, infectious diseases and neoplasias. She is the recipient of 27 research grants and has published 111 papers.


Department of Internal Medicine
University of Patras


H.M. Ashour (Biography
H.M. Ashour

Dr. Hossam M. Ashour is currently Endowed Associate Professor of Premedical Sciences at University of South Florida, St. Petersburg, Florida, USA. Dr. Ashour completed his Ph.D. (in 2006) in Immunology from University of Texas, Southwestern Medical Center, Dallas, Texas, USA. His skills and expertise mainly lie in the subject areas of Microbiology and Immunology. He is currently interested in the study of immune tolerance and autoimmune diseases. Dr. Ashour, as an author/co-author, has published more than 35 articles in various journals, having over 620 total citations.


University of South Florida
St. Petersburg, FL

Ryuichi Morishita (Biography
Ryuichi Morishita

Prof. Morishita received over 20 awards from various academic societies.

He is currently on the editorial board of over 30 scientific journals.He has published over 400 original articles and review papers. Currently, he is a member of Regulatory Affairs and also Strategic Adviser of Health Care & Medical Strategy in Abe Cabinet. He is also Special Strategic Adviser in Osaka City and Osaka Prefecture. His professional activities & appointments include Committee for Industry-Academia Relationship, Ministry of Education, Science and Culture of Japan, Vice Chairman, Bio-Venture Association Originated from Universities, and others.


Department of Clinical Gene Therapy
Osaka University

Associate Editor:

Q. Zhang (Biography
Q. Zhang

I received my Ph.D. degree in Pulmonary Medicine from Nanjing Medical University, Nanjing, Jiangsu Province, P.R. China. In 2010, I worked as a visiting scholar in the department of internal medicine at Far Eastern Memorial Hospital, Taiwan. Currently, I am working as associate chief physician, associate professor and director in the department of respiratory medicine at Changzhou No.2 People’s Hospital affiliated to Nanjing Medical University, and as postdoctor in Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu Province, P.R. China. I am interested in pulmonary medicine, critical care medicine, molecular biology, allergy and immunology.


Department of Respiratory Medicine
Nanjing Medical University

Regional Editors:

Satya N. Das (Biography
Satya N. Das

Prof. Satya N Das, obtained PhD degree from Banaras Hindu University. He is an active member of American Association and a Fellow of the National Academy of Medical Sciences. He has mentored more than 100 PG and doctoral students as guide/co-guide and published more than 120 research papers in peer-reviewed National and International journals and 25 book chapters in the area of immunology and Molecular Biology of Cancer. He edited books, ‘Essentials of Biotechnology for students’ and ‘Biotechnology in Medicine and Herbal Drug Development’. He has served Indian Immunology Society. His major area of research interest is Immunology and Molecular Biology of Cancer.


Department of Biotechnology
All India Institute of Medical Sciences
Ansari Nagar
New Delhi

Mohlopheni J. Marakalala (Biography
Mohlopheni J. Marakalala

Mohlopheni Jackson Marakalala obtained PhD at the University of Cape Town (UCT) in 2008. Postdoctoral training on innate immunology (UCT), 2008-2012. Second Postdoctoral Fellowship (2012-2015) at Harvard TH Chan School of Public (HSPH) in immunology and infectious diseases. Currently a Senior Lecturer in Immunology at UCT; also a Visiting Scientist in the Department of Immunology and Infectious Diseases, HSPH. Primary interest is on pathways that drive immunopathology during Tuberculosis progression, with a foucs on lung inflammation and granuloma progression. I am also interested in macrophage-Mtb interactions with a focus on innate immune receptors (CLRs) that recognize mycobacterial PAMPs to induce a protective immunity.


Dept of Pathology
University of Cape Town
Cape Town
South Africa

Editorial Board Members:

J.A. Allan (Biography
J.A. Allan

Dr. Allan graduated from Harvard College with an A.B. (magna cum laude) in Chemistry, and subsequently M.D. (magna cum laude) from Harvard Medical School. He also completed a postdoctoral fellowship in Transplantation Immunology at the Center for Transplantation Sciences of Massachusetts General Hospital and Harvard Medical School. Dr. Allan is on the active clinical staff in Thoracic Surgery at Massachusetts General Hospital, and is an NIH-funded principal investigator in the area of lung transplantation, with a focus on tolerance induction and xenotransplantation. Dr. Allan is a Past-President of the American Society of Transplantation.


Department of Surgery
Massachusetts General Hospital
Boston, MA

A. Badou (Biography
A. Badou

Dr. Abdallah Badou is a Professor of Immunology at the Faculty of Medicine and Pharmacy at Casablanca Hassan II University, Morocco. Dr. Badou has completed his PhD in Immunology in 1998 at Paul Sabatier University (Toulouse, France). Afterwards, He joined the Immunobiology department at Yale University School of Medicine (Connecticut, USA) from 1999 to 2007. In 2007, He joined Cadi Ayyad University in Morocco as assistant then qualified professor (2007 to 2014). Since 2014, Dr. Badou was affiliated to the Faculty of Medicine and Pharmacy of Casablanca. His current research topics are related to Immunoregulation in inflammation and cancer.


Genetics and Molecular Pathology Laboratory
University Hassan II

A. Bolhassani (Biography
A. Bolhassani

I am Dr. Azam Bolhassani working as an Associate Prof. at Hepatitis and AIDS Department in Pasteur Institute of Iran. My filed is about vaccine design against HCV, HIV, HPV infections and the use of immunotherapy and chemotherapy against cancer and the use of different adjuvants and delivery systems for enhancement of vaccine potency. We work on some different vaccines including DNA vaccine, Protein vaccine and Live vaccine and recently, VLP vaccine.


Department of Hepatitis and AIDs
Pasteur Institute of Iran

K. Hajela (Biography
K. Hajela

Prof. K. Hajela obtained PhD at the Aligarh Muslim University (AMU) India. He is presently working as Professor and Dean, Faculty of Life Sciences, Devi Ahilya University , Indore India. He has mentored 14 PhD students and 8 MPhil students as guide and co guide and authored 52 research papers. His research interest includes Lectins, lectins cell interactions, Lectin pathway of complement activation, innate immunity, MBL associated serine proteases ( MASPs).


Faculty of Life Sciences
Devi Ahilya University

F. Pica (Biography
F. Pica

Francesca Pica, MD, PhD, Specialist in Infectious Diseases. She is Associate Professor of Clinical Microbiology at the Faculty of Medicine and Surgery, University “Tor Vergata”, Rome, Italy, where she also directs a Research Lab. in Virology & Immunology. Fields of interest: Herpesvirus infections; biological and clinical aspects of the host immune response; chemo-immunotherapy protocols in immune-suppression associated with viral infections and cancer. She is a Member of the Italian Society of Microbiology, the Italian Society of Virology and the Accademia Medica di Roma.


Department of Experimental Medicine and Surgery
University of Rome ‘Tor Vergata’

E.E. Schmidt (Biography
E.E. Schmidt

Ed Schmidt earned his B.S. degree from the University of Montana and his Ph.D. from Oregon State University. Following postdocs at the University of Geneva, Switzerland with Dr. Ueli Schibler, and then at the University of Utah with Dr. Mario Capecchi, Dr. Schmidt became an Assistant Professor at Montana State University, where he currently is a Professor. His primary interests are to understand gene regulatory mechanisms that function in mammalian development and homeostasis. His work uses mouse lines that his team engineers with specific mutations. His studies integrate genetics, biochemistry, molecular biology, and genomics. The biological processes he focuses on include liver physiology and regeneration, aging, oxidative stress, immune functions, and cancer.


Department of Microbiology & Immunology
Montana State University

S. Stevens (Biography
S. Stevens

Dr. Stevens leads a group of over 22 investigators at Synthetic Genomics Inc., studying xenotransplantation in collaboration with United Therapeutics. He has led the design, creation, and use of complex genetically-modified mammalian platforms for therapeutic discovery in use at 15 of the top 20 pharmaceutical companies. Dr. Stevens and his teams have generated therapeutics, including two FDA-approved antibodies, for several indications. Dr. Stevens is an inventor on >200 US patents and applications, author of numerous articles, and served as co-PI on a Gates Foundation Grand Challenge grant. He is an advisory board member and scientific consultant for several companies.


Mammalian Synthetic Biology
Synthetic Genomics Inc
San Diego, CA

C. Argyropoulos (Biography
C. Argyropoulos

Dr. Christos Argyropoulos is a clinical and translational science researcher with over 12 years experience in these fields. His research track record includes 27 publications (which collectively have received more than 600 citations), numerous talks and poster presentations/showcases in research conferences, competitive international prices and awards and contribution of educational material in book chapters and medical journals. He received his medical and doctorate degrees in Greece, and completed his Internal Medicine residency training at the University of Cincinnati. His research career focuses on the understanding of the mechanisms of human kidney disease through the development of analytical methods for the analyses of complex biomedical data from molecules to hundreds of thousands of patients. Dr. Argyropoulos has been awarded a number of both investigator initiated and industry-sponsored awards. He is currently the Division Chief of Nephrology at the University of New Mexico, where he also functions as the Medical Director of the acute dialysis program and as the medical lead for the living and paired exchange transplant program.


School of Medicine
University of New Mexico
Albuquerque, NM

A. Blum (Biography
A. Blum

Prof. Arnon Blum received his MD at the Technion, specialized in Internal Medicine at Hebrew University, and then in Cardiology at Tel-Aviv University. Since 1999, Prof. Arnon Blum has been the Director of the Internal Medicine Ward at Baruch Padeh Medical Center—Poriya, Tiberias. Prof. Blum further concentrated on Vascular Biology and Vascular Stem Cell research, receiving his training at the National Institutes of Health (Bethesda, MD, USA; 1997-1999 and 2006-2008). In 2011-12, he was invited as a visiting Professor at the University of Miami, where he discovered a key mechanism that explains the beneficial effects of cell transplantation to the failing heart. Prof. Blum has published more than 160 papers in peer-reviewed journals.


Azrieli Faculty of Medicine
Bar-Ilan University
Ramat Gan

R. Cheynier (Biography
R. Cheynier

Dr. Rémi Cheynier obtained his PhD (1987) in Immunology from Université Paris 6 (Mention Très Honorable), France. Since 2010, Dr. Cheynier is the Research Director at Institut Cochin; Head of the group “Cytokines and Viral Infections”; Immunity, Infection, Inflammation (3I) Department; INSERM, Paris Descartes University, France. He has published over 70 articles in various international journals, 2 book chapters, and has 4 patents. His research has mainly focused on Immunology, Microbiology, and Medicine. Dr. Cheynier has membership in the following scientific socities: International Society for Mucosal Immunology, Société Française d’Immunologie, and International AIDS Society.


Institut Cochin
Equipe cytokines et infections virales

C. Haldar (Biography
C. Haldar

Prof. Haldar is renowned melatonin biologist working on the intricacies of pineal gland with eco-physiological changes in management of seasonal reproduction and immunity. She published more than 300 research papers and edited 8 books from Int. publisher.She developed a simple method for pinealectomy in Indian tropical animals and initiated the era of pineal research in India.

Established pineal organ culture to explore the functional importance of pineal proteins.

Established the role of pineal in modulation of Bone marrow cell (GM-CFU)function.

Sequenced melatonin receptor subtype MT1 and nuclear receptor.


Department of Zoology
Banaras Hindu University

L. Pavón-Romero (Biography
L. Pavón-Romero

Professor Lenin Pavón is an immunologist, since 2000, he has been the head of the Department of Psychoimmunology in the Instituto Nacional de Psiquiatría, México. His work is focused on the study of the neuro-endocrine-immune interactions in stress, major depression, fibromyalgia, schizophrenia and Alzheimer disease. Professor Pavón has published 61 articles in indexed journals and 11 chapters on specialized books. He has given more than 100 lectures by invitation at national and international academic events. Currently, he is a guest professor in the postgraduate programs in Immunology at the most important universities in his country.


Department of Psychoimmunology
National Institute of Psychiatry
“Ramón de la Fuente”, Mexico City

S. Slavin (Biography
S. Slavin

Shimon Slavin, MD, Professor of Medicine, pioneered the use of personalized anti-cancer immunotherapy mediated by donor lymphocytes and innovative methods for stem cell transplantation for malignant and non-malignant disorders, including treatment of autoimmune diseases and induction of transplantation tolerance to bone marrow and organ allografts. More recently, Slavin pioneered the use of multi-potent mesenchymal stromal cell for multi-system regenerative medicine. Slavin authors 4 books, >660 scientific publications and serves on many editorial boards and many national and international advisory boards. Slavin received many international awards in recognition of his contributions for treatment of malignant and non-malignant disorders.


Biotherapy International Weizmann Center
Tel Aviv

Associate Editorial Board Members:

A. Haghparast (Biography
A. Haghparast

Dr. Alireza R. Haghparast, D.V.M., Ph.D., is currently Associate Professor in the Department of Pathobiology (Faculty of Veterinary Medicine) at Ferdowsi University Of Mashhad (FUM), Mashhad, Iran. His skills and expertise mainly lie in the subject areas of Immunology of Infectious Diseases, Innate Immunity, Virus, Vaccine Development, Antigen, Cell Line, etc. Dr. Haghparast, as an author/co-author, has published more than 40 articles in various journals.


Department of Pathobiology
Ferdowsi University of Mashhad

Y. Zheng (Biography
Y. Zheng

Yadong Zheng, a parasitologist, received PhD in Molecular Bioscience (2012) from the University of Nottingham, UK. Zheng’s research interests are mainly focused on a role of small RNAs of parasitic pathogens in infection and immunity. In 2013, he moved to Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, and established pathogens' non-coding RNA biology group. He is Associate Editor of BMC Veterinary Research (2014-), Editorial Board Member of Asian Pacific Journal of Tropical Biomedicine (2016-2019) and member of Young Parasitologist Board of Parasitological Sub-association, China Zoological Society (2011-2020).


Lanzhou Veterinary Research Institute
Chinese Academy of Agricultural Sciences (CAAS)

S. Samuchiwal (Biography
S. Samuchiwal

Dr. Sachin Kumar Samuchiwal did Ph.D. in Molecular biology and peptide drug designing (International Centre for Genetic Engineering and Biotechnology, New Delhi, India) with four years postdoctoral experience (Harvard Medical School, Brigham and Women’s Hospital, Boston, MA) in the field of Allergy and Immunology. His research interests are (a) Host-pathogen interactions, and targeting lipid and protein mediators for understanding human asthma and allergies and developing new therapeutic regimes (b) Techniques of protein purification and protein-protein interaction.


Harvard Medical School
Brigham and Women’s Hospital
Boston, MA

C. Kirmaz (Biography
C. Kirmaz

Dr. Cengiz Kirmaz has completed most of his education (specialization in Immunology and in Internal Medicine) from Ege University (Medical Faculty), İzmir, Turkey. Since 2011, Dr. Kirmaz is Professor of Immunology and Chief of Immunology & Allergy Unit at Celal Bayar University (Department of Internal Medicine), Manisa, Turkey. His skills and expertise mainly lie in the subject areas of Lung Diseases, Immune Response, Allergic Diseases, Asthma, Airway Obstruction, Asthma Management, Respiration Disorders, etc. Dr. Kirmaz, as an author/co-author, has published more than 30 articles in various journals.


Department of Internal Medicine
Celal Bayar University

E. Rosmaraki (Biography
E. Rosmaraki

Eleftheria Rosmaraki is an Assistant Professor in Immunology, in the Department of Biology, at the University of Patras. She has graduated from the Department of Biology, University of Crete and holds an MSc degree in Immunology from Imperial College of Science, Technology & Medicine, U.K. She has completed her Ph.D. at Institut Pasteur, France and her post-doctoral studies at Karolinska Institutet, Sweden, while she has also worked as an Associate Editor for the journal Nature Reviews Clinical Oncology. Her research focuses in the development of NK cells, and the role of T and NK cells in autoimmune diseases.


Department of Biology
University of Patras

Executive Guest Editor:

T. Scorza (Biography
T. Scorza

Dr. Tatiana Scorza is a Full professor at the Department of Biological Sciences, Université du Québec à Montréal, Canada. She received her Ph.D in Immunoparasitology, from the Vrije Universiteit Brussels (Belgium). She has also served as a Research Associate at the Institute of Parasitology, McGill University, Sainte Anne-de-Bellevue, Québec, Canada. She has been awarded with the Fellowship from the Research Foundation Flandres, Belgium. Her research interests include Macrophage biology, Immune responses against blood stage malaria parasites; vaccine development, Erythropoiesis, hematopoiesis, Hemolytic anemia: effect of free heme in hematopoiesis, bone and bone marrow physiology. She has more than 20 publications and is a member of Canadian Society for Immunology.


Department of Biological Sciences
Université du Quebec à Montrea
Montreal, QC

Track Your Manuscript:


"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."

Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."

Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."

Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."

Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."

Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."

Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."

Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."

J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."

Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."

Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."

Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."

Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."

Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."

M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."

Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."

Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."

Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."

Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."

Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."

Jih Ru Hwu
(National Central University, Taiwan)

Browse Contents

Webmaster Contact:
Copyright © 2020 Bentham Open